Glendon E. French III - 01 Sep 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Issuer symbol
LUNG
Transactions as of
01 Sep 2022
Net transactions value
-$52,538
Form type
4
Filing time
06 Sep 2022, 16:50:29 UTC
Previous filing
22 Aug 2022
Next filing
19 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $18,120 -1,014 -0.1% $17.87 1,054,870 01 Sep 2022 Direct F1
transaction LUNG Common Stock Sale $34,418 -1,926 -0.18% $17.87 1,052,944 01 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022.